SINTX Technologies, Inc. (SINT)
2.03
+0.15
(+7.98%)
USD |
NASDAQ |
Sep 28, 10:55
SINTX Technologies Enterprise Value : 11.99M for Sept. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 25, 2026 | 11.99M |
| September 24, 2026 | 11.93M |
| September 23, 2026 | 11.33M |
| September 22, 2026 | 11.66M |
| September 21, 2026 | 11.20M |
| September 18, 2026 | 11.00M |
| September 17, 2026 | 10.67M |
| September 16, 2026 | 10.67M |
| September 15, 2026 | 10.80M |
| September 14, 2026 | 11.40M |
| September 11, 2026 | 11.46M |
| September 10, 2026 | 11.86M |
| September 09, 2026 | 11.60M |
| September 08, 2026 | 11.07M |
| September 04, 2026 | 10.34M |
| September 03, 2026 | 9.745M |
| September 02, 2026 | 9.613M |
| September 01, 2026 | 9.414M |
| August 31, 2026 | 9.679M |
| August 28, 2026 | 9.481M |
| August 27, 2026 | 9.679M |
| August 26, 2026 | 10.01M |
| August 25, 2026 | 9.877M |
| August 24, 2026 | 9.679M |
| August 21, 2026 | 9.811M |
| Date | Value |
|---|---|
| August 20, 2026 | 9.547M |
| August 19, 2026 | 10.08M |
| August 18, 2026 | 10.27M |
| August 17, 2026 | 10.41M |
| August 14, 2026 | 10.41M |
| August 13, 2026 | 10.87M |
| August 12, 2026 | 9.944M |
| August 11, 2026 | 11.27M |
| August 10, 2026 | 10.80M |
| August 07, 2026 | 10.54M |
| August 06, 2026 | 10.34M |
| August 05, 2026 | 11.07M |
| August 04, 2026 | 10.54M |
| August 03, 2026 | 11.27M |
| July 31, 2026 | 10.80M |
| July 30, 2026 | 9.679M |
| July 29, 2026 | 9.547M |
| July 28, 2026 | 9.877M |
| July 27, 2026 | 9.811M |
| July 24, 2026 | 8.819M |
| July 23, 2026 | 9.613M |
| July 22, 2026 | 9.877M |
| July 21, 2026 | 10.01M |
| July 20, 2026 | 9.944M |
| July 17, 2026 | 10.08M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ClearPoint Neuro, Inc. | 486.94M |
| Abbott Laboratories | 202.93B |
| AngioDynamics, Inc. | 603.03M |
| Alphatec Holdings, Inc. | 2.054B |
| AtriCure, Inc. | 2.876B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.706M |
| Revenue (Quarterly) | 0.452M |
| Total Expenses (Quarterly) | 3.158M |
| EPS Diluted (Quarterly) | -0.749 |
| Gross Profit Margin (Quarterly) | 61.50% |
| Profit Margin (Quarterly) | -598.7% |
| Earnings Yield | -269.5% |
| Normalized Earnings Yield | -271.32 |